| Financial Year |
March 31 2023 |
| Monetary Funds |
231,621,565.83 |
| Held-for-trading Financial Assets |
2,299,785,717.69 |
| Notes Receivable |
96,172,829.79 |
| Accounts Receivable |
148,323,939.42 |
| Advances to Suppliers |
9,208,826.31 |
| Other Receivables |
2,537,977.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
174,297,512.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,279,382.49 |
| Total Current Assets |
3,059,338,833.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
104,596,942.19 |
| Investment Properties |
100,186,340.23 |
| Fixed Assetes |
127,280,897.80 |
| Under-construction Projects |
5,851,673.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,146,866.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,613,480.08 |
| Deferred Income Tax Assets |
32,184,747.01 |
| Other Non-Current Assets |
1,307,089.98 |
| Sub-Total of Non-Current Assets |
589,051,192.08 |
| Total Assets |
3,648,390,025.19 |
| Short-Term Loans |
20,024,133.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
120,153,719.77 |
| Accounts Payable |
81,781,935.06 |
| Accounts Received In Advance |
2,276,409.74 |
| Employee Compensation Payable |
3,897,783.68 |
| Taxes Payable |
10,115,568.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,432,792.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
3,543,923.81 |
| Sub-Total of Current Liabilities |
307,106,706.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,717,721.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,508,000.15 |
| Total Liabilities |
324,614,706.92 |
| Paid-In Capital(Or Share Stock) |
834,049,096.00 |
| Capital Surplus |
1,226,902,466.15 |
| Surplus Reserve |
180,026,696.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,020,667,090.27 |
| Minority Stockholder's Interest |
49,080,398.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,274,694,919.54 |
| Owner's Equity（Stockholder's Equity） |
3,323,775,318.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,648,390,025.19 |
